FeaturesSignalPricingFounders
Log inGet started free
BC

Biomedical Catalyst Fund

Venture CapitalModerate

Biomedical Catalyst Fund invests in the pre-clinical development and early clinical testing of novel therapeutics.

Swindon, United KingdomFounded 2011gov.uk
9
Investments
1
Exits
—
AUM
11.1%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Biomedical Catalyst Fund.

Get started free

Investment Thesis & Strategy

Biomedical Catalyst Fund invests in pre-clinical and early clinical stage therapeutics, focusing on novel therapeutics.

Investment Activity

Deals per year over the last 6 years

2
2007
3
2008
0
2009
3
2010
0
2011
2
2012

Portfolio Companies

Selected investments from their portfolio of 9 companies

M
Mission Therapeutics
Biotech · Series A, 2012
Active
A
Autifony Therapeutics
Biotech · Series A, 2012
Active
A
Abliva
Biotech · Series A, 2010
Active
A
Adaptimmune Therapeutics
Biotech · Series A, 2010
Active
K
Kymab
Biotech · Series A, 2010
Active
H
Heptares Therapeutics
Biotech · Series A, 2008
Active
F
F-star Therapeutics
Biotech · Series A, 2008
Active
A
Almac Discovery
Biotech · Series A, 2008
Active
I
Immunocore
Biotech · Series A, 2007
Active
S
Syntaxin
Biotech · Series A, 2007
Active

Frequently Asked Questions

Biomedical Catalyst Fund focuses on Series A, Series B, Series C+ stage investments.

Related Investors

Innovate UK

Swindon, United Kingdom · 329 deals

Bessemer Venture Partners

Redwood City, United States · 971 deals

Threshold

Menlo Park, United States · 841 deals

Lightspeed Venture Partners

Menlo Park, United States · 839 deals

Index Ventures

San Francisco, United States · 827 deals

Andreessen Horowitz

Menlo Park, United States · 826 deals